Mobile-health Network Solutions (MNDR) 股票分析

公司概述

Mobile-health Network Solutions operates as an investment holding company focused on delivering telehealth solutions, primarily serving the Singapore market through its specialized healthcare offerings. The company functions within the broader Healthcare sector and specifically within the Health Information Services industry, positioning itself to facilitate the digital transformation of medical service delivery and information management. In terms of operational scale, the firm employs 73 individuals and maintains a market capitalization of $3.01M, while reporting annual revenue (TTM) of $7.32M. These valuation and revenue figures indicate that the company is a micro-cap entity with a relatively small market footprint, suggesting it is an early-stage or niche player that has not yet achieved the scale typical of large-cap healthcare infrastructure providers.

财务健康

The company reported a total revenue of $7.32M for the trailing twelve months, yet posted a net income of $-2,586,343 and an EBITDA of $-2,503,371, revealing a significant gap between top-line generation and bottom-line profitability. This substantial divergence between revenue and net income highlights a cost structure where operating expenses and other deductions significantly erode the gross proceeds, resulting in a net loss that exceeds the EBITDA loss. Regarding liquidity and financial flexibility, the available data lists Free Cash Flow as N/A, which implies that the company is currently in a cash-burn phase where capital expenditures or working capital requirements are consuming available liquidity. The balance sheet shows a cash position of $3.48M against total debt of $115,463, creating a scenario where cash assets vastly outweigh liabilities. However, the Debt to Equity ratio stands at 1.39, indicating a leveraged capital structure where equity is less than the total debt load, despite the positive cash cushion. Profitability metrics further illustrate operational challenges, with a Gross Margin of 19.7%, an Operating Margin of -22.2%, and a Profit Margin of -35.3%, signaling that the company struggles to convert revenue into profit at current operational levels. Liquidity management is supported by a Current Ratio of 4.22, suggesting strong short-term solvency as current assets are more than four times current liabilities. Finally, the Return on Equity is -47.6% and the Return on Assets is -23.5%, metrics that reveal that management has not yet been effective in generating positive returns on shareholder capital or the asset base due to the persistent losses.

估值评估

The company currently has a Trailing P/E ratio and Forward P/E ratio listed as N/A, a common characteristic for firms with negative earnings where traditional earnings-based valuation multiples are mathematically undefined. In the absence of a P/E multiple, the Price to Book ratio serves as a primary valuation metric, standing at 0.35, which indicates that the market values the company at 35% of its book value, implying a significant market discount relative to the net asset value. Alternative valuation metrics provide additional context, with a Price to Sales ratio of 0.41 and an EV/EBITDA of 0.20, suggesting that investors are pricing the firm based on minimal sales multiples and extremely low enterprise value multiples due to the negative earnings profile. The stock price has exhibited high volatility within the reporting period, trading between a 52-Week High of $9.01 and a 52-Week Low of $0.76. Without the current share price explicitly listed in the facts to calculate the exact percentage deviation, the range itself demonstrates a wide trading band of over $8.00, reflecting substantial price swings typical of low-market-cap stocks. The Beta value is listed as N/A, meaning there is no available historical data to quantify the company's price volatility relative to the broader market index, though the wide 52-week range suggests inherent instability.

Growth & Income

The company experienced a Revenue Growth (YoY) of -7.7%, while Earnings Growth (YoY) is listed as N/A due to the negative earnings baseline, indicating that the firm is currently contracting rather than expanding its top line. Since the company does not pay dividends, as evidenced by a Dividend Yield of N/A and a Payout Ratio of 0.0%, it does not distribute earnings to shareholders but instead retains all capital, theoretically reinvesting it into operations to address the negative growth and losses. The absence of a dividend yield and the negative earnings growth profile characterize the firm as a high-risk, non-income investment that offers no current cash return to investors. Overall, the growth and income profile is defined by negative revenue expansion and a complete lack of dividend income, positioning the asset strictly as a speculative play on potential future turnaround rather than a vehicle for capital appreciation or income generation.